Labcorp Holdings (LH) Receivables - Other (2012 - 2026)

Labcorp Holdings has reported Receivables - Other for 12 years, with the latest figure at $161.9 million in Q1 2026.

• Quarterly Receivables - Other rose 7.01% year-over-year to $161.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $161.9 million (up 7.01% YoY) and the FY2025 annual result came in at $156.9 million, up 2.62% from the prior year.
• Receivables - Other advanced to $161.9 million in Q1 2026 per LH's latest filing, from $156.9 million in the prior quarter.
• Over five years, Receivables - Other peaked at $827.4 million in Q2 2022 and troughed at $108.0 million in Q3 2023.
• A 5-year average of $304.3 million and a median of $157.5 million in 2024 frame the typical range for Receivables - Other.
• The sharpest annual moves came in 2023 and 2024: Receivables - Other tumbled 86.81% in 2023, then jumped 53.98% in 2024.
• Over 5 years, Receivables - Other stood at $211.8 million in 2022, then fell by 12.46% to $185.4 million in 2023, then slipped by 17.53% to $152.9 million in 2024, then grew by 2.62% to $156.9 million in 2025, then increased by 3.19% to $161.9 million in 2026.
• According to Business Quant data, Receivables - Other over the past three periods registered $161.9 million, $156.9 million, and $156.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.